65,437 trials
Nicotine Dependence
Primary: Maximum Concentration of Nicotine in Plasma (Cmax) — 5.7; 11.8; 6.7; 8.1 ng/mL
Foot Injuries and Disorders
Primary: PROMIS Patient Reported Outcomes for Physical Function — 44.78; 45.02 score on a scale
Suicide Prevention
Primary: Change in Late Positive Potential, as Measured by the Electroencephalagram (EEG), Autobiographical Affective Regulation Task (AART), and a Standard Picture-based Emotion…
Alcohol Dependence · Nicotine Dependence
Primary: Continuous Smoking Abstinence in the Last 4 Weeks of Treatment Continuous Smoking Abstinence in the Last 4 Weeks of Treatment — 2; 5; 6 participants
Herpes Simplex Oral
Primary: Duration (Days) of Herpes Labialis Outbreak Until Healed — 10.6; 8.25 days
NSCLC
Primary: PFS Rate at 18 Months — 51.1; 67.2; 53.5 Percentage of participants
Acute Ischemic Stroke
Primary: Interleukin - 1b - Changes and Differences in the Levels — -0.222; 0.327 percent change/day — p=0.24
Peripheral Artery Disease
Primary: Changes in Walking Distance After Three-months Intervention — 289.68; 262.95 meters
Amputation · Prosthesis User · Residual Limbs
Primary: Trans-Epidermal Water Loss (TEWL) — 22.9; 14.7 g x m^-2xh^-1
Mental Health · Depression · Post-Traumatic Stress Disorder
Primary: System Usability Scale (SUS) — 76.15 score on a scale
Lobular Breast Carcinoma · Gastric Cancer · Triple Negative Breast Cancer
Primary: Percentage of Breast Cancer Cohort Participants With Confirmed Response Assessed Using RECIST v1.1 — 1 Participants
Insomnia
Primary: Change in Daytime Insomnia Symptoms Scale (DISS) — 65.96; 70.34; 69.22; 72.32 units on a scale
Chronic Plantar Fasciitis
Primary: Visual Analog Scale Score - General Heel Tenderness — 46.7; 47.5 score on a scale
Epilepsy
Primary: Anti-seizure Medication Adherence Rate — 68.93; 77.23 score on a scale
Non-anemic Iron Deficiency
Primary: Early Learning Composite (ELC) From the Mullen Scales of Early Learning — 113.0; 113.5; 110.48; 107.94 units on a scale